Skip to content

NORTHWEST BIOTHERAPEUTICS INC: filings

Every NORTHWEST BIOTHERAPEUTICS INC annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 2026441190001104659-26-097188
10-Q2026-05-15fiscal Q1 202642840001104659-26-062661
10-K2026-04-15fiscal FY 202543840001104659-26-043806
10-Q2025-11-14fiscal Q3 2025381060001104659-25-112676
10-Q2025-08-14fiscal Q2 2025381060001410578-25-001825
10-Q2025-05-15fiscal Q1 202538770001410578-25-001333
10-K2025-03-31fiscal FY 202438750001410578-25-000598
10-Q2024-11-12fiscal Q3 2024381050001410578-24-001879
10-Q2024-08-09fiscal Q2 2024381050001410578-24-001278
10-Q2024-05-10fiscal Q1 202436740001410578-24-000741
10-K2024-03-05fiscal FY 202338950001410578-24-000133
10-Q2023-11-09fiscal Q3 2023371030001410578-23-002304
10-Q2023-08-09fiscal Q2 2023361020001410578-23-001633
10-Q2023-05-10fiscal Q1 202335730001410578-23-000976
10-K2023-02-28fiscal FY 202236930001410578-23-000185
10-Q2022-11-09fiscal Q3 2022351010001410578-22-003073
10-Q2022-08-09fiscal Q2 202234990001410578-22-002177
10-Q2022-05-10fiscal Q1 202233690001410578-22-001218
10-K2022-03-01fiscal FY 202137970001410578-22-000244
10-Q2021-11-15fiscal Q3 202132920001104659-21-139211
10-Q2021-08-16fiscal Q2 202133960001104659-21-106389
10-Q2021-05-17fiscal Q1 202133690001104659-21-068299
10-K2021-03-31fiscal FY 202031650001104659-21-044832
10-Q2021-01-15fiscal Q3 202029810001104659-21-004396
10-Q2020-08-10fiscal Q2 2020341000001104659-20-092797
10-Q2020-06-24fiscal Q1 202034690001104659-20-076154
10-K2020-03-16fiscal FY 201932650001104659-20-034145
10-Q2019-11-12fiscal Q3 2019341010001104659-19-062726
10-Q2019-08-09fiscal Q2 2019331000001144204-19-038889
10-Q2019-05-10fiscal Q1 201930630001144204-19-025347
10-K2019-04-02fiscal FY 201829610001144204-19-017803
10-Q2018-11-16fiscal Q3 201829860001144204-18-060568
10-Q2018-08-14fiscal Q2 201825700001144204-18-044727
10-Q2018-05-16fiscal Q1 201824500001144204-18-029266
10-K2018-04-17fiscal FY 201730620001144204-18-020971
10-Q2017-11-20fiscal Q3 201728730001144204-17-060217
10-Q2017-08-21fiscal Q2 201724620001144204-17-044412
10-Q2017-05-15fiscal Q1 201723460001144204-17-027650
10-K2017-04-17fiscal FY 201627550001144204-17-020754
10-Q2016-11-10fiscal Q3 201629840001144204-16-133328
10-Q2016-08-09fiscal Q2 201625680001144204-16-117776
10-Q2016-05-11fiscal Q1 201627560001144204-16-100593
10-K2016-03-16fiscal FY 201533990001144204-16-088301
10-Q2015-11-09fiscal Q3 201533920001144204-15-063856
10-Q2015-08-10fiscal Q2 201528700001144204-15-047830
10-Q2015-05-11fiscal Q1 201528560001144204-15-029414
10-K2015-03-17fiscal FY 201428570001144204-15-016579
10-Q2014-11-19fiscal Q3 201425650001144204-14-069728
10-Q2014-08-15fiscal Q2 201420540001144204-14-050484
10-Q2014-05-15fiscal Q1 201421560001144204-14-031414
10-K2014-04-01fiscal FY 2013271000001144204-14-020023
10-Q2013-11-15fiscal Q3 201322700001144204-13-062315
10-Q2013-08-14fiscal Q2 201324750001144204-13-046070
10-Q2013-05-15fiscal Q1 201323600001144204-13-029641
10-K2013-04-08fiscal FY 201224620001144204-13-020507
10-Q2012-11-14fiscal Q3 201229960001144204-12-062199
10-Q/A2012-09-12fiscal Q2 201227840001144204-12-050900
10-Q2012-05-21fiscal Q1 201227690001144204-12-030833
10-K2012-04-13fiscal FY 201127990001144204-12-021574
10-Q2011-11-14fiscal Q3 201128900001144204-11-064125
10-Q2011-08-15fiscal Q2 201124740001144204-11-047212

Inspect the source

Entity
NORTHWEST BIOTHERAPEUTICS INC / CIK 0001072379
Captured
2026-09-20T05:19:52.407Z
SEC response SHA-256
96ae5155e1f371497ff4e69acb04404a27b3c3c6ef981ce6f22dae4793393c44

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001072379.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))